ESC Premium Access

Comparison of various non-invasive tools for diagnosing AL cardiac amyloidosis.

Topic: Cardiomyopathies

Congress Presentation

About the speaker

Doctor Martin Nicol

Hospital Lariboisiere, Paris (France)
1 presentation
0 follower

6 more presentations in this session

Investigation of left ventricular function and biomarkers following treatment in patients with light-chain cardiac amyloidosis

Thumbnail

Predictors of progression of light-chain cardiac amyloidosis.

Speaker: Doctor V. Rameev (Moscow, RU)

Thumbnail

Prognosis of patients with cardiac amyloidosis referred in the French cardiac amyloidosis expert center.

Speaker: Professor T. Damy (Creteil, FR)

Thumbnail

AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy

Speaker: Associate Professor M. Alhamadsheh (Stockton, US)

Thumbnail

Long-term evolution of longitudinal myocardial deformation in the natural history of familial amyloid polyneuropathy

Speaker: Doctor G. Lima Da Silva (Lisbon, PT)

Thumbnail

Access the full session

Cardiac amyloidosis

Speakers: Doctor M. Nicol, Doctor V. Rameev, Professor T. Damy, Associate Professor M. Alhamadsheh, Doctor G. Lima Da Silva
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb